Member Info for Chris0123

Life span extended! (from infusion announcements) P1 - 6 months 16 days P2 - 4 months 7 days P3 - 26 days (we know they are through the 28 - announcement imminent. Total 11 months 25 days, effectively 1 full year combined for these patients. Health conditions had to be right for all pre infusion but 1 FULL YEAR where no adverse affects or supplementary treatment evident or reported. That's got to be considered incredible in this sphere of work.

After several email exchanges LSE have fully understood that the Top 5 should be Top 5 throughout the LSE platform.

They said:

"This would relate to the further change the technical team needed to make, which has since been done this morning. Any rise the share has should be reflected on all parts of the website now."

Where we should be!

I think most has been said this morning. I would say that last night was like I remember Christmas Eve, anticipating with excitement the morning surprise. (How I miss that hoop, stick and tangarine!) Well, Santa came and went, but as is the norm you will get relatives visiting throughout the Christmas period and we will receive more pReseNtS over the coming weeks. Might even take a Turkey to a destiture shorter if this hits £50 per share. Fron Deck the Halls - "Follow me in merry treasure, Fa la la la la la la la !

Crunch & Pwil yes point of principle now and getting annoyed with LSE now. Yescwe should be top of top 5. The data douce must be the same so have asked this morning whether Hemogenyx are being deliberately held back and why subscribers ain't seeing accurate info. AscI say Pointon principle now.

Re this week...when sitting under water (not now thankfully) you look at your target and think how the heck can I get to 30; 40 ; 50 + quid SP target. What has delighted me this week is that on "good" money alone coming in (thanks Jhfh Haywain et al) this SP can motor. With news to come from a number of milestones this share iscreally hoping to accelerate. This week was my inflection point! Strap in folks Bones is tinkering with the Starship Enterprise engine. GLA

Diggitt - this is becoming "Carry On Hemo" but I hope they do carry on the way they have this week..can't wait until Monday.

"...no issue with people keeping their shorts open..." Let's keep this forum for share chat please JHFH !!!

We've made further changes to include stocks that aren't listed in an Index like the FTSE100, 250, etc, so in future everything should show regardless if it's listed in an Index.

We didn't show shares that weren't in an Index as showing everything would include irrelevant international stocks. As an example, the top riser yesterday was an international chinese stock that the majority of people wouldn't be interested in.

Looks like they have sorted it!!!

Davie contacted LSE thrice. Full of rubbish in their response. First answer go andvtalknto software. Still no change. Reported again was told Hemogenyx are not indexed..ask them what the hell that means and still waiting a response. Told them we should be on first page top 5. Doesn't add up. Not good enough. Fullnof sh* *e

You are probably thinking P1 update.

Patient 1 - 6 months update - ended on 24th August - hope we hear something soon. ASH may be just too far away not to share something.

What are you expecting the content of the RNS to be? Genuine enquiry.

Posteed earlier JHFH and there have been more since all timed the same. - Walked down as you say.

Batches of 6 sells - same time on 4 time slots

14:59; 15:04; 15:13; 15:17 5 small and 1 larger.

Slight variations but a pattern all the same.

Batches of 6 sells - same time on 4 time slots

14:59; 15:04; 15:13; 15:17 5 small and 1 larger.

Slight variations but a pattern all the same.

Exceptional Circumstances"15 Aug 2025 11:43

FDA allowing change in clinical trial protocol in "exceptional circumstances" - AI states "The FDA may allow changes during a clinical trial under 'exceptional circunstances', primarily when patients face lif-threatening situations or irreversible morbidity, and no comparable alternative treatment exists. AI also added "the potential benefit ...must outweigh the potential risks" Therefore, it follows that the FDA can only make this decision on evidence received and that evidence is clearly how well P1 & P2 are doing and the fact that there are no other options in the market place. If Hemogenyx get this right they will be unrivalled.

No harm done guys, LSE should really sort themselves out though!

Qualified that Saint but on balance the exposure argument outweighs that - been under a bushel too long , time to kick ass.

Message back from LSE

"I have passed this onto our developers as to why its not showing on the Homepage of the website in the top 5 so they will look into why".

Not convinced its a glitch but we'll see.

But hey we'll appear there next week - we all dream! Good to see ypu posting TW

Up 59% Top Riser of the day and still can't get onto the front page of LSE's 5 Top Risers.

I know we don't want to attract the wrong uns but some exposure may attract something of value as an investment. We are largely holding the gains that's the important thing to note so we have draw some good attention from investors as well traders.

I have pointed this out to LSE.

Hung by his own pertard!

Aldebaran you "eventually" invested / traded your money on the back of the long-standing relationships between investors on this board who respected and trusted each other and the company enough to join forces and place this latest investment in the company.

If mentioning Avacta in almost every post (on the Hemo bb no less) is not being obsessed, what is?

Aldebaran you seem hell bent on consolidating your deserved alienated position on this board. You slate the very people who saw the potential in this company early on. Those who have stuck with the company through thick and thin. Were it not for these investors there might not have been a Hemogenyx for you to invest in to make your few quid. If most underwater shareholders can manage to maintain their dignity, I am sure you can hold your own counsel when you get your wee profit. There's a saying, "be careful who you tread on on the way up, you might meet them on the way down"